{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T01:19:36Z","timestamp":1789867176285,"version":"4.0.1"},"reference-count":125,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,7,1]],"date-time":"2016-07-01T00:00:00Z","timestamp":1467331200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,7,1]],"date-time":"2016-07-01T00:00:00Z","timestamp":1467331200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Autoimmunity"],"published-print":{"date-parts":[[2016,7]]},"DOI":"10.1016\/j.jaut.2016.05.002","type":"journal-article","created":{"date-parts":[[2016,5,23]],"date-time":"2016-05-23T15:32:40Z","timestamp":1464017560000},"page":"69-77","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"special_numbering":"C","title":["Regulatory mechanisms of immune tolerance in type 1 diabetes and their failures"],"prefix":"10.1016","volume":"71","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5610-4795","authenticated-orcid":false,"given":"Chantal","family":"Kuhn","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alix","family":"Besan\u00e7on","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00e9bastien","family":"Lemoine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvaine","family":"You","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cindy","family":"Marquet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Candon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucienne","family":"Chatenoud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaut.2016.05.002_bib1","first-page":"723","article-title":"Cell interactions in the induction of tolerance: the role of thymic lymphocytes","volume":"18","author":"Gershon","year":"1970","journal-title":"Immunology"},{"key":"10.1016\/j.jaut.2016.05.002_bib2","first-page":"903","article-title":"Infectious immunological tolerance","volume":"21","author":"Gershon","year":"1971","journal-title":"Immunology"},{"key":"10.1016\/j.jaut.2016.05.002_bib3","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1126\/science.2113314","article-title":"A\u00a0cell culture model for T lymphocyte clonal anergy","volume":"248","author":"Schwartz","year":"1990","journal-title":"Science"},{"key":"10.1016\/j.jaut.2016.05.002_bib4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1084\/jem.184.1.1","article-title":"Models of T cell anergy: is there a common molecular mechanism? comment","volume":"184","author":"Schwartz","year":"1996","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.jaut.2016.05.002_bib5","doi-asserted-by":"crossref","first-page":"2348","DOI":"10.4049\/jimmunol.136.7.2348","article-title":"Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins","volume":"136","author":"Mosmann","year":"1986","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.jaut.2016.05.002_bib6","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1146\/annurev.iy.07.040189.001045","article-title":"TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties","volume":"7","author":"Mosmann","year":"1989","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.jaut.2016.05.002_bib7","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1034\/j.1600-065X.2001.1820112.x","article-title":"Suppressor T cells\u2013they\u2019re back and critical for regulation of autoimmunity!","volume":"182","author":"Chatenoud","year":"2001","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.jaut.2016.05.002_bib8","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1210\/edrv-15-4-516","article-title":"Insulin-dependent diabetes mellitus as an autoimmune disease","volume":"15","author":"Bach","year":"1994","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.jaut.2016.05.002_bib9","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1146\/annurev.immunol.19.1.131","article-title":"Tolerance to islet autoantigens in type 1 diabetes","volume":"19","author":"Bach","year":"2001","journal-title":"Annl. Rev. Immunol."},{"key":"10.1016\/j.jaut.2016.05.002_bib10","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/0896-8411(91)90021-4","article-title":"Prevention of diabetes in NOD mice treated with antibody to murine IFN gamma","volume":"4","author":"Debray-Sachs","year":"1991","journal-title":"J.\u00a0Autoimmun."},{"key":"10.1016\/j.jaut.2016.05.002_bib11","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.4049\/jimmunol.163.3.1178","article-title":"Induction of glutamic acid decarboxylase 65-specific Th2 cells and suppression of autoimmune diabetes at late stages of disease is epitope dependent","volume":"163","author":"Tisch","year":"1999","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.jaut.2016.05.002_bib12","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1084\/jem.183.4.1561","article-title":"Nasal administration of glutamate decarboxylase (GAD65) peptides induces Th2 responses and prevents murine insulin-dependent diabetes","volume":"183","author":"Tian","year":"1996","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.jaut.2016.05.002_bib13","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1084\/jem.181.2.817","article-title":"Interleukin 12 administration induces T helper type 1 cells and accelerates autoimmune diabetes in NOD mice","volume":"181","author":"Trembleau","year":"1995","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.jaut.2016.05.002_bib14","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/S1074-7613(00)80323-4","article-title":"CD28\/B7 regulation of Th1 and Th2 subsets in the development of autoimmune diabetes","volume":"5","author":"Lenschow","year":"1996","journal-title":"Immunity"},{"key":"10.1016\/j.jaut.2016.05.002_bib15","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/S1074-7613(00)80195-8","article-title":"B7\/CD28 costimulation is essential for the homeostasis of the CD4+CD25+ immunoregulatory T cells that control autoimmune diabetes","volume":"12","author":"Salomon","year":"2000","journal-title":"Immunity"},{"key":"10.1016\/j.jaut.2016.05.002_bib16","doi-asserted-by":"crossref","first-page":"812","DOI":"10.2337\/diab.45.6.812","article-title":"Genetic absence of gamma-interferon delays but does not prevent diabetes in NOD mice","volume":"45","author":"Hultgren","year":"1996","journal-title":"Diabetes"},{"key":"10.1016\/j.jaut.2016.05.002_bib17","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.2337\/diab.47.8.1207","article-title":"Interleukin-4 deficiency does not exacerbate disease in NOD mice","volume":"47","author":"Wang","year":"1998","journal-title":"Diabetes"},{"key":"10.1016\/j.jaut.2016.05.002_bib18","doi-asserted-by":"crossref","first-page":"240","DOI":"10.4049\/jimmunol.164.1.240","article-title":"Characterization of peripheral regulatory CD4(+) T cells that prevent diabetes onset in nonobese diabetic mice","volume":"164","author":"Lepault","year":"2000","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.jaut.2016.05.002_bib19","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1038\/icb.1997.72","article-title":"Protection from autoimmune diabetes by adjuvant therapy in the non-obese diabetic mouse: the role of interleukin-4 and interleukin-10","volume":"75","author":"Calcinaro","year":"1997","journal-title":"Immunol. Cell Biol."},{"key":"10.1016\/j.jaut.2016.05.002_bib20","doi-asserted-by":"crossref","first-page":"2072","DOI":"10.4049\/jimmunol.150.5.2072","article-title":"Complete Freund\u2019s adjuvant-induced T cells prevent the development and adoptive transfer of diabetes in nonobese diabetic mice","volume":"150","author":"Qin","year":"1993","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.jaut.2016.05.002_bib21","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.4049\/jimmunol.166.2.1352","article-title":"Th1 to Th2 cytokine shifts in nonobese diabetic mice: sometimes an outcome, rather than the cause, of diabetes resistance elicited by immunostimulation","volume":"166","author":"Serreze","year":"2001","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.jaut.2016.05.002_bib22","first-page":"88","article-title":"Ontogeny of regulatory and effector T cells in autoimmune NOD mice","volume":"vol. 19","author":"Yasunami","year":"1990"},{"key":"10.1016\/j.jaut.2016.05.002_bib23","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1007\/BF00408468","article-title":"Evidence of CD4+ regulatory T cells in the non-obese diabetic male mouse","volume":"37","author":"Sempe","year":"1994","journal-title":"Diabetologia"},{"key":"10.1016\/j.jaut.2016.05.002_bib24","doi-asserted-by":"crossref","first-page":"855","DOI":"10.2337\/diab.35.8.855","article-title":"Transfer of autoimmune diabetes mellitus with splenocytes from nonobese diabetic (NOD) mice","volume":"35","author":"Wicker","year":"1986","journal-title":"Diabetes"},{"key":"10.1016\/j.jaut.2016.05.002_bib25","first-page":"229","article-title":"R\u00e9action crois\u00e9e entre les antig\u00e8nes de classe II du complexe majeur d\u2019histocompatibilit\u00e9 de la souris NOD et un antig\u00e8ne insulaire de poids mol\u00e9culaire de 58 kDa","volume":"309","author":"Boitard","year":"1989","journal-title":"C.\u00a0R. Acad. Sci. III"},{"key":"10.1016\/j.jaut.2016.05.002_bib26","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1084\/jem.169.5.1669","article-title":"T\u00a0cell-mediated inhibition of the transfer of autoimmune diabetes in NOD mice","volume":"169","author":"Boitard","year":"1989","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.jaut.2016.05.002_bib27","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1002\/eji.1830190516","article-title":"Acceleration of the onset of diabetes in NOD mice by thymectomy at weaning","volume":"19","author":"Dardenne","year":"1989","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.jaut.2016.05.002_bib28","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1084\/jem.184.2.387","article-title":"Autoimmune disease as a consequence of developmental abnormality of a T cell subpopulation","volume":"184","author":"Asano","year":"1996","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.jaut.2016.05.002_bib29","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.4049\/jimmunol.155.3.1151","article-title":"Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases","volume":"155","author":"Sakaguchi","year":"1995","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.jaut.2016.05.002_bib30","doi-asserted-by":"crossref","first-page":"6603","DOI":"10.4049\/jimmunol.177.10.6603","article-title":"Cyclophosphamide-induced type-1 diabetes in the NOD mouse is associated with a reduction of CD4+CD25+Foxp3+ regulatory T cells","volume":"177","author":"Brode","year":"2006","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.jaut.2016.05.002_bib31","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1038\/nri1026","article-title":"Regulatory T cells under scrutiny","volume":"3","author":"Bach","year":"2003","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.jaut.2016.05.002_bib32","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1038\/nri1032","article-title":"Natural versus adaptive regulatory T cells","volume":"3","author":"Bluestone","year":"2003","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.jaut.2016.05.002_bib33","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1073\/pnas.45.4.554","article-title":"Exceptional inheritance of a sex-linked gene in the mouse explained on the basis that the x\/o sex-chromosome constitution is female","volume":"45","author":"Russell","year":"1959","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jaut.2016.05.002_bib34","doi-asserted-by":"crossref","first-page":"5528","DOI":"10.1073\/pnas.88.13.5528","article-title":"Fatal lymphoreticular disease in the scurfy (sf) mouse requires T cells that mature in a sf thymic environment: potential model for thymic education","volume":"88","author":"Godfrey","year":"1991","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jaut.2016.05.002_bib35","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/S0022-3476(82)80573-8","article-title":"An X-linked syndrome of diarrhea, polyendocrinopathy, and fatal infection in infancy","volume":"100","author":"Powell","year":"1982","journal-title":"J.\u00a0Pediatr."},{"key":"10.1016\/j.jaut.2016.05.002_bib36","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1038\/83713","article-title":"The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3","volume":"27","author":"Bennett","year":"2001","journal-title":"Nat. Genet."},{"key":"10.1016\/j.jaut.2016.05.002_bib37","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1038\/83707","article-title":"X-linked neonatal diabetes mellitus, enteropathy and endocrinopathy syndrome is the human equivalent of mouse scurfy","volume":"27","author":"Wildin","year":"2001","journal-title":"Nat. Genet."},{"key":"10.1016\/j.jaut.2016.05.002_bib38","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1038\/83784","article-title":"Disruption of a new forkhead\/winged-helix protein, scurfin, results in the fatal lymphoproliferative disorder of the scurfy mouse","volume":"27","author":"Brunkow","year":"2001","journal-title":"Nat. Genet."},{"key":"10.1016\/j.jaut.2016.05.002_bib39","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.immuni.2013.03.002","article-title":"Development and maintenance of regulatory T cells","volume":"38","author":"Ohkura","year":"2013","journal-title":"Immunity"},{"key":"10.1016\/j.jaut.2016.05.002_bib40","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1126\/science.1079490","article-title":"Control of regulatory T cell development by the transcription factor Foxp3","volume":"299","author":"Hori","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.jaut.2016.05.002_bib41","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/ni904","article-title":"Foxp3 programs the development and function of CD4+CD25+ regulatory T cells","volume":"4","author":"Fontenot","year":"2003","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.jaut.2016.05.002_bib42","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/ni909","article-title":"An essential role for Scurfin in CD4+CD25+ T regulatory cells","volume":"4","author":"Khattri","year":"2003","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.jaut.2016.05.002_bib43","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1038\/ni1428","article-title":"Regulatory T cells prevent catastrophic autoimmunity throughout the lifespan of mice","volume":"8","author":"Kim","year":"2007","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.jaut.2016.05.002_bib44","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1084\/jem.20061852","article-title":"Selective depletion of Foxp3+ regulatory T cells induces a scurfy-like disease","volume":"204","author":"Lahl","year":"2007","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.jaut.2016.05.002_bib45","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1084\/jem.20030152","article-title":"Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3","volume":"198","author":"Chen","year":"2003","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.jaut.2016.05.002_bib46","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1002\/eji.201444577","article-title":"Epigenetic control of thymic Treg-cell development","volume":"45","author":"Kitagawa","year":"2015","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.jaut.2016.05.002_bib47","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1111\/imr.12174","article-title":"Genetic and epigenetic basis of Treg cell development and function: from a FoxP3-centered view to an epigenome-defined view of natural Treg cells","volume":"259","author":"Morikawa","year":"2014","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.jaut.2016.05.002_bib48","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1038\/nature08750","article-title":"Role of conserved non-coding DNA elements in the Foxp3 gene in regulatory T-cell fate","volume":"463","author":"Zheng","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.jaut.2016.05.002_bib49","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1038\/ni.1795","article-title":"Runx-CBFbeta complexes control expression of the transcription factor Foxp3 in regulatory T cells","volume":"10","author":"Rudra","year":"2009","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.jaut.2016.05.002_bib50","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1038\/nature11581","article-title":"Novel Foxo1-dependent transcriptional programs control T(reg) cell function","volume":"491","author":"Ouyang","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.jaut.2016.05.002_bib51","doi-asserted-by":"crossref","first-page":"5289","DOI":"10.1073\/pnas.1312717110","article-title":"Differential roles of epigenetic changes and Foxp3 expression in regulatory T cell-specific transcriptional regulation","volume":"111","author":"Morikawa","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jaut.2016.05.002_bib52","doi-asserted-by":"crossref","first-page":"6335","DOI":"10.1073\/pnas.0701171104","article-title":"Adaptive TGF-beta-dependent regulatory T cells control autoimmune diabetes and are a privileged target of anti-CD3 antibody treatment","volume":"104","author":"You","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jaut.2016.05.002_bib53","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1111\/j.0105-2896.2006.00410.x","article-title":"Transforming growth factor-beta and T-cell-mediated immunoregulation in the control of autoimmune diabetes","volume":"212","author":"You","year":"2006","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.jaut.2016.05.002_bib54","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.2337\/db05-1576","article-title":"Induction of tolerance in type 1 diabetes via both CD4+CD25+ T regulatory cells and T regulatory type 1 cells","volume":"55","author":"Battaglia","year":"2006","journal-title":"Diabetes"},{"key":"10.1016\/j.jaut.2016.05.002_bib55","doi-asserted-by":"crossref","first-page":"425021","DOI":"10.1155\/2012\/425021","article-title":"Induction of immunological tolerance by oral anti-CD3","volume":"2012","author":"da Cunha","year":"2012","journal-title":"Clin. Dev. Immunol."},{"key":"10.1016\/j.jaut.2016.05.002_bib56","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1111\/imr.12160","article-title":"tTregs, pTregs, and iTregs: similarities and differences","volume":"259","author":"Shevach","year":"2014","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.jaut.2016.05.002_bib57","doi-asserted-by":"crossref","first-page":"3433","DOI":"10.4049\/jimmunol.0904028","article-title":"Expression of Helios, an Ikaros transcription factor family member, differentiates thymic-derived from peripherally induced Foxp3+ T regulatory cells","volume":"184","author":"Thornton","year":"2010","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.jaut.2016.05.002_bib58","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1084\/jem.20120914","article-title":"Neuropilin 1 is expressed on thymus-derived natural regulatory T cells, but not mucosa-generated induced Foxp3+ T reg cells","volume":"209","author":"Weiss","year":"2012","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.jaut.2016.05.002_bib59","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1084\/jem.20120822","article-title":"Neuropilin-1 distinguishes natural and inducible regulatory T cells among regulatory T cell subsets in\u00a0vivo","volume":"209","author":"Yadav","year":"2012","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.jaut.2016.05.002_bib60","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1038\/nature12721","article-title":"Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells","volume":"504","author":"Furusawa","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.jaut.2016.05.002_bib61","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1038\/nature12726","article-title":"Metabolites produced by commensal bacteria promote peripheral regulatory T-cell generation","volume":"504","author":"Arpaia","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.jaut.2016.05.002_bib62","doi-asserted-by":"crossref","unstructured":"Esterhazy D, Loschko J, London M, Jove V, Oliveira TY, Mucida D. Classical dendritic cells are required for dietary antigen-mediated induction of peripheral Treg cells and tolerance. 2016; 17: 545\u201355.","DOI":"10.1038\/ni.3408"},{"key":"10.1016\/j.jaut.2016.05.002_bib63","first-page":"858","article-title":"Dietary antigens limit mucosal immunity by inducing regulatory T cells in the small intestine","volume":"351","author":"Kim","year":"2016","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.jaut.2016.05.002_bib64","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/j.immuni.2008.03.016","article-title":"Central role of defective interleukin-2 production in the triggering of islet autoimmune destruction","volume":"28","author":"Tang","year":"2008","journal-title":"Immunity"},{"key":"10.1016\/j.jaut.2016.05.002_bib65","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1084\/jem.20100209","article-title":"IL-2 reverses established type 1 diabetes in NOD mice by a local effect on pancreatic regulatory T cells","volume":"207","author":"Grinberg-Bleyer","year":"2010","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.jaut.2016.05.002_bib66","doi-asserted-by":"crossref","first-page":"4558","DOI":"10.1172\/JCI42945","article-title":"Pathogenic T cells have a paradoxical protective effect in murine autoimmune diabetes by boosting Tregs","volume":"120","author":"Grinberg-Bleyer","year":"2010","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.jaut.2016.05.002_bib67","doi-asserted-by":"crossref","first-page":"999","DOI":"10.4049\/jimmunol.1400504","article-title":"Effector T cells boost regulatory T cell expansion by IL-2, TNF, OX40, and plasmacytoid dendritic cells depending on the immune context","volume":"194","author":"Baeyens","year":"2015","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.jaut.2016.05.002_bib68","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1038\/ng1958","article-title":"Interleukin-2 gene variation impairs regulatory T cell function and causes autoimmunity","volume":"39","author":"Yamanouchi","year":"2007","journal-title":"Nat. Genet."},{"key":"10.1016\/j.jaut.2016.05.002_bib69","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/S2213-8587(13)70113-X","article-title":"Low-dose interleukin 2 in patients with type 1 diabetes: a phase 1\/2 randomised, double-blind, placebo-controlled trial","volume":"1","author":"Hartemann","year":"2013","journal-title":"Lancet Diabetes Endocrinol."},{"key":"10.1016\/j.jaut.2016.05.002_bib70","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1038\/nri3823","article-title":"The promise of low-dose interleukin-2 therapy for autoimmune and inflammatory diseases","volume":"15","author":"Klatzmann","year":"2015","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.jaut.2016.05.002_bib71","doi-asserted-by":"crossref","first-page":"e009799","DOI":"10.1136\/bmjopen-2015-009799","article-title":"Protocol of the adaptive study of IL-2 dose frequency on regulatory T cells in type 1 diabetes (DILfrequency): a mechanistic, non-randomised, repeat dose, open-label, response-adaptive study","volume":"5","author":"Truman","year":"2015","journal-title":"BMJ Open"},{"key":"10.1016\/j.jaut.2016.05.002_bib72","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.2337\/diabetes.54.5.1415","article-title":"Autoimmune diabetes onset results from qualitative rather than quantitative age-dependent changes in pathogenic T-cells","volume":"54","author":"You","year":"2005","journal-title":"Diabetes"},{"key":"10.1016\/j.jaut.2016.05.002_bib73","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/j.1365-2567.2007.02546.x","article-title":"Diabetes in non-obese diabetic mice is not associated with quantitative changes in CD4+ CD25+ Foxp3+ regulatory T cells","volume":"121","author":"Mellanby","year":"2007","journal-title":"Immunology"},{"key":"10.1016\/j.jaut.2016.05.002_bib74","doi-asserted-by":"crossref","first-page":"4040","DOI":"10.4049\/jimmunol.171.8.4040","article-title":"Dynamics of pathogenic and suppressor T cells in autoimmune diabetes development","volume":"171","author":"Gregori","year":"2003","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.jaut.2016.05.002_bib75","doi-asserted-by":"crossref","first-page":"19857","DOI":"10.1073\/pnas.0810713105","article-title":"The defect in T-cell regulation in NOD mice is an effect on the T-cell effectors","volume":"105","author":"D\u2019Alise","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jaut.2016.05.002_bib76","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1038\/nm1564","article-title":"Myelin-specific regulatory T cells accumulate in the CNS but fail to control autoimmune inflammation","volume":"13","author":"Korn","year":"2007","journal-title":"Nat. Med."},{"key":"10.1016\/j.jaut.2016.05.002_bib77","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1038\/ajg.2011.397","article-title":"Impaired control of effector T cells by regulatory T cells: a clue to loss of oral tolerance and autoimmunity in celiac disease?","volume":"107","author":"Hmida","year":"2012","journal-title":"Am. J. Gastroenterol."},{"key":"10.1016\/j.jaut.2016.05.002_bib78","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1111\/j.1365-2249.2008.03810.x","article-title":"Increased resistance to CD4+CD25hi regulatory T cell-mediated suppression in patients with type 1 diabetes","volume":"154","author":"Lawson","year":"2008","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.jaut.2016.05.002_bib79","doi-asserted-by":"crossref","first-page":"7350","DOI":"10.4049\/jimmunol.181.10.7350","article-title":"The effector T cells of diabetic subjects are resistant to regulation via CD4+ FOXP3+ regulatory T cells","volume":"181","author":"Schneider","year":"2008","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.jaut.2016.05.002_bib80","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1007\/s10875-008-9248-6","article-title":"Role of endogenous and induced regulatory T cells during infections","volume":"28","author":"Wohlfert","year":"2008","journal-title":"J.\u00a0Clin. Immunol."},{"key":"10.1016\/j.jaut.2016.05.002_bib81","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.it.2007.02.003","article-title":"\u2018Vive la Resistance!\u2019\u2013the PI3K-Akt pathway can determine target sensitivity to regulatory T cell suppression","volume":"28","author":"Wohlfert","year":"2007","journal-title":"Trends Immunol."},{"key":"10.1016\/j.jaut.2016.05.002_bib82","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/sj.leu.2404453","article-title":"Enhanced CD28 signaling may be a common mechanism underlying resistance to regulation","volume":"21","author":"Wohlfert","year":"2007","journal-title":"Leukemia"},{"key":"10.1016\/j.jaut.2016.05.002_bib83","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.4049\/jimmunol.176.3.1316","article-title":"Cutting edge: deficiency in the E3 ubiquitin ligase Cbl-b results in a multifunctional defect in T cell TGF-beta sensitivity in\u00a0vitro and in\u00a0vivo","volume":"176","author":"Wohlfert","year":"2006","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.jaut.2016.05.002_bib84","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1097\/00007890-198112000-00018","article-title":"Treatment of acute renal allograft rejection with OKT3 monoclonal antibody","volume":"32","author":"Cosimi","year":"1981","journal-title":"Transplantation"},{"key":"10.1016\/j.jaut.2016.05.002_bib85","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1056\/NEJM198108063050603","article-title":"Use of monoclonal antibodies to T-cell subsets for immunologic monitoring and treatment in recipients of renal allografts","volume":"305","author":"Cosimi","year":"1981","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.jaut.2016.05.002_bib86","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1097\/00007890-198803000-00009","article-title":"One-month prophylactic use of OKT3 in cadaver kidney transplant recipients","volume":"45","author":"Debure","year":"1988","journal-title":"Transplantation"},{"key":"10.1016\/j.jaut.2016.05.002_bib87","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1097\/00007890-198904000-00008","article-title":"Release of tumor necrosis factor, interleukin-2, and gamma-interferon in serum after injection of OKT3 monoclonal antibody in kidney transplant recipients","volume":"47","author":"Abramowicz","year":"1989","journal-title":"Transplantation"},{"key":"10.1016\/j.jaut.2016.05.002_bib88","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1038\/nri1000","article-title":"CD3-specific antibody-induced active tolerance: from bench to bedside","volume":"3","author":"Chatenoud","year":"2003","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.jaut.2016.05.002_bib89","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1097\/00007890-199004000-00009","article-title":"In\u00a0vivo cell activation following OKT3 administration. Systemic cytokine release and modulation by corticosteroids","volume":"49","author":"Chatenoud","year":"1990","journal-title":"Transplantation"},{"key":"10.1016\/j.jaut.2016.05.002_bib90","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1038\/nm924","article-title":"TGF-beta-dependent mechanisms mediate restoration of self-tolerance induced by antibodies to CD3 in overt autoimmune diabetes","volume":"9","author":"Belghith","year":"2003","journal-title":"Nat. Med."},{"key":"10.1016\/j.jaut.2016.05.002_bib91","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1038\/nrendo.2009.275","article-title":"Immune therapy for type 1 diabetes mellitus-what is unique about anti-CD3 antibodies?","volume":"6","author":"Chatenoud","year":"2010","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.jaut.2016.05.002_bib92","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1038\/nri2134","article-title":"CD3-specific antibodies : a portal to the treatment of autoimmunity","volume":"7","author":"Chatenoud","year":"2007","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.jaut.2016.05.002_bib93","doi-asserted-by":"crossref","first-page":"4525","DOI":"10.4049\/jimmunol.174.8.4525","article-title":"Treatment with nonmitogenic anti-CD3 monoclonal antibody induces CD4+ T cell unresponsiveness and functional reversal of established experimental autoimmune encephalomyelitis","volume":"174","author":"Kohm","year":"2005","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.jaut.2016.05.002_bib94","doi-asserted-by":"crossref","first-page":"3622","DOI":"10.4049\/jimmunol.159.7.3622","article-title":"TGF-beta production regulates the development of the 2,4,6-trinitrophenol-conjugated keyhole limpet hemocyanin-induced colonic inflammation in IL-2-deficient mice","volume":"159","author":"Ludviksson","year":"1997","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.jaut.2016.05.002_bib95","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1038\/nm1749","article-title":"CD3-specific antibody-induced immune tolerance involves transforming growth factor-beta from phagocytes digesting apoptotic T cells","volume":"14","author":"Perruche","year":"2008","journal-title":"Nat. Med."},{"key":"10.1016\/j.jaut.2016.05.002_bib96","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1038\/nm1408","article-title":"Oral CD3-specific antibody suppresses autoimmune encephalomyelitis by inducing CD4(+)CD25(-)LAP(+) T cells","volume":"12","author":"Ochi","year":"2006","journal-title":"Nat. Med."},{"key":"10.1016\/j.jaut.2016.05.002_bib97","doi-asserted-by":"crossref","first-page":"2947","DOI":"10.4049\/jimmunol.158.6.2947","article-title":"CD3 antibody-induced dominant self tolerance in overtly diabetic NOD mice","volume":"158","author":"Chatenoud","year":"1997","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.jaut.2016.05.002_bib98","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1073\/pnas.91.1.123","article-title":"Anti-CD3 antibody induces long-term remission of overt autoimmunity in nonobese diabetic mice","volume":"91","author":"Chatenoud","year":"1994","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jaut.2016.05.002_bib99","doi-asserted-by":"crossref","first-page":"68ra10","DOI":"10.1126\/scitranslmed.3001830","article-title":"Human CD3 transgenic mice: preclinical testing of antibodies promoting immune tolerance","volume":"3","author":"Kuhn","year":"2011","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.jaut.2016.05.002_bib100","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.08133","article-title":"TGFbeta-dependent expression of PD-1 and PD-L1 controls CD8(+) T cell anergy in transplant tolerance","volume":"5","author":"Baas","year":"2016","journal-title":"Elife"},{"key":"10.1016\/j.jaut.2016.05.002_bib101","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1111\/ajt.13477","article-title":"Control of immune response to allogeneic embryonic stem cells by CD3 antibody-mediated operational tolerance induction","volume":"16","author":"Calderon","year":"2016","journal-title":"Am. J. Transpl."},{"key":"10.1016\/j.jaut.2016.05.002_bib102","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1111\/ajt.12272","article-title":"Delayed anti-CD3 therapy results in depletion of alloreactive T cells and the dominance of Foxp3+ CD4+ graft infiltrating cells","volume":"13","author":"Goto","year":"2013","journal-title":"Am. J. Transpl."},{"key":"10.1016\/j.jaut.2016.05.002_bib103","doi-asserted-by":"crossref","first-page":"2909","DOI":"10.1111\/j.1600-6143.2012.04213.x","article-title":"Induction of allograft tolerance by monoclonal CD3 antibodies: a matter of timing","volume":"12","author":"You","year":"2012","journal-title":"Am. J. Transpl."},{"key":"10.1016\/j.jaut.2016.05.002_bib104","first-page":"4696","article-title":"Combining autologous dendritic cell therapy with CD3 antibodies promotes regulatory T cells and permanent islet\u00a0allograft acceptance","volume":"193","author":"Baas","year":"2014","journal-title":"Diabetes"},{"key":"10.1016\/j.jaut.2016.05.002_bib105","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0065-2776(08)00802-X","article-title":"CD3 antibodies as unique tools to restore self-tolerance in established autoimmunity their mode of action and clinical application in type 1 diabetes","volume":"100","author":"You","year":"2008","journal-title":"Adv. Immunol."},{"key":"10.1016\/j.jaut.2016.05.002_bib106","doi-asserted-by":"crossref","first-page":"118ra12","DOI":"10.1126\/scitranslmed.3003401","article-title":"Teplizumab induces human gut-tropic regulatory cells in humanized mice and patients","volume":"4","author":"Waldron-Lynch","year":"2012","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.jaut.2016.05.002_bib107","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.2337\/diabetes.54.6.1763","article-title":"A\u00a0single course of anti-CD3 monoclonal antibody hOKT3gamma1(Ala-Ala) results in improvement in C-peptide responses and clinical parameters for at least 2 years after onset of type 1 diabetes","volume":"54","author":"Herold","year":"2005","journal-title":"Diabetes"},{"key":"10.1016\/j.jaut.2016.05.002_bib108","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1056\/NEJMoa012864","article-title":"Anti-CD3 monoclonal antibody in new-onset type 1 diabetes mellitus","volume":"346","author":"Herold","year":"2002","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.jaut.2016.05.002_bib109","doi-asserted-by":"crossref","first-page":"2598","DOI":"10.1056\/NEJMoa043980","article-title":"Insulin needs after CD3-antibody therapy in new-onset type 1 diabetes","volume":"352","author":"Keymeulen","year":"2005","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.jaut.2016.05.002_bib110","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1007\/s00125-009-1644-9","article-title":"Four-year metabolic outcome of a randomised controlled CD3-antibody trial in recent-onset type 1 diabetic patients depends on their age and baseline residual beta cell mass","volume":"53","author":"Keymeulen","year":"2010","journal-title":"Diabetologia"},{"key":"10.1016\/j.jaut.2016.05.002_bib111","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/S0140-6736(11)60931-8","article-title":"Teplizumab for treatment of type 1 diabetes (Protege study): 1-year results from a randomised, placebo-controlled trial","volume":"378","author":"Sherry","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.jaut.2016.05.002_bib112","first-page":"S1521","article-title":"Anti-CD3 clinical trials in type 1 diabetes mellitus","volume":"13","author":"Daifotis","year":"2013","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.jaut.2016.05.002_bib113","first-page":"39","article-title":"Tr1 cells and the counter-regulation of immunity: natural mechanisms and therapeutic applications","volume":"380","author":"Roncarolo","year":"2014","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"10.1016\/j.jaut.2016.05.002_bib114","doi-asserted-by":"crossref","DOI":"10.1053\/j.gastro.2012.07.116","article-title":"Safety and efficacy of antigen-specific regulatory T-cell therapy for patients with refractory Crohn\u2019s disease","volume":"143","author":"Desreumaux","year":"2012","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jaut.2016.05.002_bib115","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1111\/j.1600-065X.2011.01010.x","article-title":"Clinical tolerance in allogeneic hematopoietic stem cell transplantation","volume":"241","author":"Roncarolo","year":"2011","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.jaut.2016.05.002_bib116","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1038\/nature16962","article-title":"Expanding antigen-specific regulatory networks to treat autoimmunity","volume":"530","author":"Clemente-Casares","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.jaut.2016.05.002_bib117","doi-asserted-by":"crossref","first-page":"5136","DOI":"10.1210\/en.2007-0358","article-title":"Exendin-4 improves reversal of diabetes in NOD mice treated with anti-CD3 monoclonal antibody by enhancing recovery of beta-cells","volume":"148","author":"Sherry","year":"2007","journal-title":"Endocrinology"},{"key":"10.1016\/j.jaut.2016.05.002_bib118","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1172\/JCI27191","article-title":"Anti-CD3 and nasal proinsulin combination therapy enhances remission from recent-onset autoimmune diabetes by inducing Tregs","volume":"116","author":"Bresson","year":"2006","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.jaut.2016.05.002_bib119","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/mt.2009.197","article-title":"Genetic-induced variations in the GAD65 T-cell repertoire governs efficacy of anti-CD3\/GAD65 combination therapy in new-onset type 1 diabetes","volume":"18","author":"Bresson","year":"2010","journal-title":"Mol. Ther."},{"key":"10.1016\/j.jaut.2016.05.002_bib120","doi-asserted-by":"crossref","first-page":"2849","DOI":"10.2337\/db12-1175","article-title":"Combination treatment with anti-CD20 and oral anti-CD3 prevents and reverses autoimmune diabetes","volume":"62","author":"Hu","year":"2013","journal-title":"Diabetes"},{"key":"10.1016\/j.jaut.2016.05.002_bib121","doi-asserted-by":"crossref","unstructured":"Lasch S, Muller P, Bayer M, Pfeilschifter JM, Luster AD, Hintermann E, et\u00a0al. Anti-CD3\/Anti-CXCL10 Antibody Combination Therapy Induces a Persistent Remission of Type 1 Diabetes in Two Mouse Models. 2015; 64: 4198\u2013211.","DOI":"10.2337\/db15-0479"},{"key":"10.1016\/j.jaut.2016.05.002_bib122","doi-asserted-by":"crossref","first-page":"e77296","DOI":"10.1371\/journal.pone.0077296","article-title":"Therapeutic use of a selective S1P1 receptor modulator ponesimod in autoimmune diabetes","volume":"8","author":"You","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.jaut.2016.05.002_bib123","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1210\/en.2015-1549","article-title":"Prolactin as an adjunct for type 1 diabetes immunotherapy","volume":"157","author":"Hyslop","year":"2016","journal-title":"Endocrinology"},{"key":"10.1016\/j.jaut.2016.05.002_bib124","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1038\/nri2233","article-title":"Creating immune privilege: active local suppression that benefits friends, but protects foes","volume":"8","author":"Mellor","year":"2008","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.jaut.2016.05.002_bib125","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.smim.2006.01.010","article-title":"Regulatory T cells in transplantation","volume":"18","author":"Waldmann","year":"2006","journal-title":"Semin. Immunol."}],"container-title":["Journal of Autoimmunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0896841116300531?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0896841116300531?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T08:13:32Z","timestamp":1760256812000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0896841116300531"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7]]},"references-count":125,"alternative-id":["S0896841116300531"],"URL":"https:\/\/doi.org\/10.1016\/j.jaut.2016.05.002","relation":{},"ISSN":["0896-8411"],"issn-type":[{"value":"0896-8411","type":"print"}],"subject":[],"published":{"date-parts":[[2016,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Regulatory mechanisms of immune tolerance in type 1 diabetes and their failures","name":"articletitle","label":"Article Title"},{"value":"Journal of Autoimmunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaut.2016.05.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}